contract_awardAwarded Tuesday, May 26, 2026Analyzed

REVELATIONS COUNSELING & CONSULTING, LLC: $15.1M Department of Veterans Affairs Contract

Neutral

Summary

This $15.1M contract from the Department of Veterans Affairs to Revelations Counseling & Consulting, LLC for caregiver support financial and legal services is a private entity award with no direct public company beneficiary. The contract supports VA caregiver programs, but no publicly traded tickers can be reliably mapped.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.Contract recipient is private, no public ticker exposure.
  • 2.VA caregiver support contracts are routine and small relative to market.
  • 3.No actionable stock implications from this award.

Market Implications

This contract has no direct market implications for publicly traded equities. The $15.1M award is a routine VA service contract to a private entity, and no tickers can be reliably associated. Investors should focus on larger, public-facing VA contracts for actionable signals.

Full Analysis

The Department of Veterans Affairs awarded a $15.1M definitive contract to Revelations Counseling & Consulting, LLC for the VHA Caregiver Support Program Financial and Legal Services. The contract period runs from May 2026 to May 2027. Since the recipient is a private limited liability company and not a publicly traded entity or recognized subsidiary of a public company, no direct stock impact can be attributed. The contract falls under the Healthcare sector, specifically supporting veteran caregiver services. Related legislation such as HR2878 (Daniel J. Harvey, Jr. and Adam Lambert Improving Servicemember Transition to Reduce Veteran Suicide Act) and HR8737 (expanding VA community care for mental health) signal ongoing congressional focus on veteran healthcare, but these bills are neutral with low impact scores and do not directly fund this contract. Without a public company recipient, supply chain beneficiaries cannot be reliably identified without risking false positives. Historical patterns for private VA contracts show limited direct market impact, though the broader veteran services sector may see incremental growth from sustained legislative attention.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderMay 29, 2026

Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries

This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.

Exec OrderApr 30, 2026

Promoting Efficiency, Accountability, and Performance in Federal Contracting

This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.

Exec OrderApr 18, 2026

Accelerating Medical Treatments for Serious Mental Illness

This executive order directs the FDA to prioritize review and facilitate 'Right to Try' access for psychedelic drugs, including ibogaine compounds, that have received Breakthrough Therapy designation for serious mental illnesses. It also allocates $50 million from HHS to support state programs advancing these treatments and mandates collaboration between HHS, FDA, VA, and the private sector to increase clinical trial participation and data sharing for these drugs. The Attorney General is further directed to expedite rescheduling reviews for approved Schedule I psychedelic substances.

Contract Details

Recipient

REVELATIONS COUNSELING & CONSULTING, LLC

Award Amount

$15,099,629

Awarding Agency

Department of Veterans Affairs

Sub-Agency

Department of Veterans Affairs

Contract Type

DEFINITIVE CONTRACT

Related Bills

HR2878HR8737